Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Planned phase II programme of marizomib for solid tumours.

Trial Profile

Planned phase II programme of marizomib for solid tumours.

Phase of Trial: Phase II

Latest Information Update: 22 Apr 2008

At a glance

  • Drugs Marizomib (Primary) ; Vorinostat
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Sponsors Nereus Pharmaceuticals; Triphase Accelerator Corporation
  • Most Recent Events

    • 22 Apr 2008 New trial record.
    • 19 Apr 2008 Nereus plans to initiate this trial in 2009, following successful completion of the phase Ib trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top